Corporate Statement

Mallinckrodt Pharmaceuticals is a multibillion dollar specialty pharmaceutical company focused on our mission: Listening for Needs. Delivering Solutions. We provide medicines to address unmet patient needs, stemming from 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future.

Investor Overview

News Releases

06 Sep '23
Mallinckrodt Receives U.S. Food and Drug Administration Label Update for StrataGraft® (allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen – dsat) Reducing Xenotransplantation Requirements – The FDA no longer restricts donation of human cells, tissues, cellular or
go back to the top of the page